Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ESstevia is a biotechnology company focused on the development and commercialization of high-quality stevia-based sweeteners. The company utilizes advanced breeding techniques and proprietary extraction processes to produce steviol glycosides with improved taste profiles, specifically targeting the reduction of bitterness often associated with natural sweeteners. By providing zero-calorie alternatives to sugar, ESstevia supports the management of metabolic conditions such as obesity and diabetes. Their business model encompasses the entire value chain from seed development to the supply of refined extracts for the global food and beverage industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ESstevia.